TCRR insider filings

TCR2 THERAPEUTICS INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-02-14. Screen TCRR transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for TCRR between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — TCR2 THERAPEUTICS INC.

FiledFormInsiderReported transactionsSource
2024-02-144TANG KEVIN C — 10% owner
TANG CAPITAL MANAGEMENT LLC — 10% owner
TANG CAPITAL PARTNERS LP — 10% owner
Other (J): 4,394,800EDGAR
2023-06-054MPM SunStates Fund, L.P. — 10% owner
MPM Asset Management Investors SunStates Fund LLC — 10% owner
MPM SunStates Fund GP LLC — 10% owner
MPM SunStates GP Managing Member LLC — 10% owner
Other (J): 4,158,964 @ $0EDGAR
2023-06-054UBS Oncology Impact Fund L.P. — 10% owner
Oncology Impact Fund (Cayman) Management L.P. — 10% owner
BioImpact Capital LLC — 10% owner
Other (J): 3,370,982 @ $0EDGAR
2023-06-054MPM BioVentures 2014, L.P. — 10% owner
Foley Todd — 10% owner
EVNIN LUKE — 10% owner
MPM BioVentures 2014 (B), L.P. — 10% owner
MPM Asset Management Investors BV2014 LLC — 10% owner
MPM BioVentures 2014 LLC — 10% owner
MPM BioVentures 2014 GP LLC — 10% owner
MPM ASSET MANAGEMENT LLC — 10% owner
Other (J): 4,158,964 @ $0EDGAR
2023-06-054GADICKE ANSBERT — Director, 10% ownerOther (J): 304,001 @ $0 · Other (J): 3,854,963 @ $0 · Other (J): 3,370,982 @ $0EDGAR
2023-06-014Cardama Alfonso Quintas — Chief Medical OfficerDisposition to issuer (D): 109,459 · Disposition to issuer (D): 70,649 (derivative) @ $0 · Disposition to issuer (D): 31,582 (derivative) @ $0 · Disposition to issuer (D): 42,346 (derivative) @ $0 · Disposition to issuer (D): 90,720 (derivative) @ $0 · Disposition to issuer (D): 114,700 (derivative) @ $0 · +4 moreEDGAR
2023-06-014Olagunju Peter — Chief Operating OfficerDisposition to issuer (D): 24,092 · Disposition to issuer (D): 98,124 (derivative) @ $0 · Disposition to issuer (D): 47,100 (derivative) @ $0 · Disposition to issuer (D): 16,354 (derivative) @ $0 · Disposition to issuer (D): 62,047 (derivative) @ $0EDGAR
2023-06-014Harrison Rosemary — Chief Business & StrategyDisposition to issuer (D): 76,930 (derivative) @ $0 · Disposition to issuer (D): 12,822 (derivative) @ $0 · Disposition to issuer (D): 191,102 (derivative) @ $0EDGAR
2023-06-014Hoos Axel — DirectorDisposition to issuer (D): 16,800 (derivative) @ $0 · Disposition to issuer (D): 9,596 (derivative) @ $0 · Disposition to issuer (D): 12,100 (derivative) @ $0 · Disposition to issuer (D): 12,100 (derivative) @ $0EDGAR
2023-06-014Hegde Priti — DirectorDisposition to issuer (D): 16,800 (derivative) @ $0 · Disposition to issuer (D): 12,100 (derivative) @ $0 · Disposition to issuer (D): 24,968 (derivative) @ $0EDGAR
2023-06-014Justice Angela — Chief People OfficerDisposition to issuer (D): 48,745 · Disposition to issuer (D): 78,499 (derivative) @ $0 · Disposition to issuer (D): 76,500 (derivative) @ $0 · Disposition to issuer (D): 13,083 (derivative) @ $0 · Disposition to issuer (D): 13,527 (derivative) @ $0 · Disposition to issuer (D): 1,050 (derivative) @ $0 · +1 moreEDGAR
2023-06-014Tomasello Shawn — DirectorDisposition to issuer (D): 16,800 (derivative) @ $0 · Disposition to issuer (D): 12,100 (derivative) @ $0 · Disposition to issuer (D): 15,191 (derivative) @ $0 · Disposition to issuer (D): 4,177 (derivative) @ $0EDGAR
2023-06-014Sullivan Eric — Chief Financial OfficerDisposition to issuer (D): 40,820 (derivative) @ $0 · Disposition to issuer (D): 250,000 (derivative) @ $0 · Disposition to issuer (D): 6,804 (derivative) @ $0EDGAR
2023-06-014Menzel Garry E — President and CEO, DirectorDisposition to issuer (D): 132,729 · Disposition to issuer (D): 132,730 · Disposition to issuer (D): 138,871 · Disposition to issuer (D): 138,031 (derivative) @ $0 · Disposition to issuer (D): 433,037 (derivative) @ $0 · Disposition to issuer (D): 305,800 (derivative) @ $0 · +5 moreEDGAR
2023-06-014Gibson Neil W — DirectorDisposition to issuer (D): 16,800 (derivative) @ $0 · Disposition to issuer (D): 6,270 (derivative) @ $0 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 12,100 (derivative) @ $0 · Disposition to issuer (D): 12,100 (derivative) @ $0 · Disposition to issuer (D): 8,072 (derivative) @ $0EDGAR
2023-06-014Webster Stephen W — DirectorDisposition to issuer (D): 16,800 (derivative) @ $0 · Disposition to issuer (D): 12,100 (derivative) @ $0 · Disposition to issuer (D): 12,100 (derivative) @ $0 · Disposition to issuer (D): 10,482 (derivative) @ $0EDGAR
2023-06-014Allen Andrew R — DirectorDisposition to issuer (D): 16,800 (derivative) @ $0 · Disposition to issuer (D): 12,100 (derivative) @ $0 · Disposition to issuer (D): 12,100 (derivative) @ $0 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 6,270 (derivative) @ $0 · Disposition to issuer (D): 8,072 (derivative) @ $0EDGAR
2023-05-304TANG KEVIN C — 10% owner
TANG CAPITAL MANAGEMENT LLC — 10% owner
TANG CAPITAL PARTNERS LP — 10% owner
Purchase (P): 50,000 @ $1.72EDGAR
2023-05-244MPM ASSET MANAGEMENT LLC — 10% owner
EVNIN LUKE — 10% owner
Option exercise/expiry (X): 178,269 @ $0.74 · Sale (S): 70,170 @ $1.88 · Option exercise/expiry (X): 42,761 (derivative) @ $0 · Option exercise/expiry (X): 135,508 (derivative) @ $0EDGAR
2023-05-244GADICKE ANSBERT — Director, 10% ownerOption exercise/expiry (X): 178,269 @ $0.74 · Sale (S): 70,170 @ $1.88 · Option exercise/expiry (X): 42,761 (derivative) @ $0 · Option exercise/expiry (X): 135,508 (derivative) @ $0EDGAR
2023-05-154TANG KEVIN C — 10% owner
TANG CAPITAL MANAGEMENT LLC — 10% owner
TANG CAPITAL PARTNERS LP — 10% owner
Purchase (P): 38,765 @ $1.95 · Purchase (P): 6,183 @ $1.95EDGAR
2023-05-104TANG KEVIN C — 10% owner
TANG CAPITAL MANAGEMENT LLC — 10% owner
TANG CAPITAL PARTNERS LP — 10% owner
Purchase (P): 57,073 @ $1.95 · Purchase (P): 20,141 @ $1.95 · Purchase (P): 6,774 @ $1.95EDGAR
2023-05-054TANG KEVIN C — 10% owner
TANG CAPITAL MANAGEMENT LLC — 10% owner
TANG CAPITAL PARTNERS LP — 10% owner
Purchase (P): 18,513 @ $1.85 · Purchase (P): 104,241 @ $1.86 · Purchase (P): 95,759 @ $1.90 · Purchase (P): 71,064 @ $1.94EDGAR
2022-12-194Cardama Alfonso Quintas — Chief Medical OfficerGrant/award (A): 70,649 (derivative) @ $0 · Grant/award (A): 11,775 (derivative) @ $0EDGAR
2022-12-194Olagunju Peter — Chief Technical OfficerGrant/award (A): 98,124 (derivative) @ $0 · Grant/award (A): 16,354 (derivative) @ $0EDGAR
2022-12-194Hoos Axel — DirectorGrant/award (A): 16,800 (derivative) @ $0EDGAR
2022-12-194Hegde Priti — DirectorGrant/award (A): 16,800 (derivative) @ $0EDGAR
2022-12-194Harrison Rosemary — Chief Business & StrategyGrant/award (A): 76,930 (derivative) @ $0 · Grant/award (A): 12,822 (derivative) @ $0EDGAR
2022-12-194Justice Angela — Chief People OfficerGrant/award (A): 78,499 (derivative) @ $0 · Grant/award (A): 13,083 (derivative) @ $0EDGAR
2022-12-194Tomasello Shawn — DirectorGrant/award (A): 16,800 (derivative) @ $0EDGAR
2022-12-194Sullivan Eric — Chief Financial OfficerGrant/award (A): 40,820 (derivative) @ $0 · Grant/award (A): 6,804 (derivative) @ $0EDGAR
2022-12-194Menzel Garry E — President and CEO, DirectorGrant/award (A): 238,008 (derivative) @ $0 · Grant/award (A): 39,681 (derivative) @ $0EDGAR
2022-12-194Gibson Neil W — DirectorGrant/award (A): 16,800 (derivative) @ $0EDGAR
2022-12-194Webster Stephen W — DirectorGrant/award (A): 16,800 (derivative) @ $0EDGAR
2022-12-194Allen Andrew R — DirectorGrant/award (A): 16,800 (derivative) @ $0EDGAR
2022-12-134Cardama Alfonso Quintas — Chief Medical OfficerSale (S): 4,461 @ $1.13 · Sale (S): 4,586 @ $1.10 · Sale (S): 4,752 @ $1.06EDGAR
2022-12-134Olagunju Peter — Chief Technical OfficerSale (S): 1,561 @ $1.13 · Sale (S): 1,610 @ $1.10 · Sale (S): 1,659 @ $1.06EDGAR
2022-12-134Justice Angela — Chief People OfficerSale (S): 2,792 @ $1.13 · Sale (S): 2,865 @ $1.10 · Sale (S): 2,963 @ $1.06EDGAR
2022-12-134Menzel Garry E — President and CEO, DirectorSale (S): 10,325 @ $1.13 · Sale (S): 10,613 @ $1.10 · Sale (S): 11,000 @ $1.06EDGAR
2022-12-094Cardama Alfonso Quintas — Chief Medical OfficerSale (S): 3,928 @ $1.28 · Sale (S): 4,014 @ $1.26EDGAR
2022-12-094Olagunju Peter — Chief Technical OfficerSale (S): 1,378 @ $1.28 · Sale (S): 1,410 @ $1.25EDGAR
2022-12-094Justice Angela — Chief People OfficerSale (S): 2,457 @ $1.28 · Sale (S): 2,511 @ $1.25EDGAR
2022-12-094Menzel Garry E — President and CEO, DirectorSale (S): 9,111 @ $1.28 · Sale (S): 9,314 @ $1.25EDGAR
2022-12-074Cardama Alfonso Quintas — Chief Medical OfficerSale (S): 3,686 @ $1.37 · Sale (S): 3,778 @ $1.33EDGAR
2022-12-074Olagunju Peter — Chief Technical OfficerSale (S): 1,291 @ $1.37 · Sale (S): 1,327 @ $1.33EDGAR
2022-12-074Justice Angela — Chief People OfficerSale (S): 2,302 @ $1.37 · Sale (S): 2,361 @ $1.33EDGAR
2022-12-074Menzel Garry E — President and CEO, DirectorSale (S): 8,530 @ $1.37 · Sale (S): 14,886 @ $1.35EDGAR
2022-12-054Olagunju Peter — Chief Technical OfficerOption exercise (M): 33,409 · Sale (S): 1,273 @ $1.39 · Option exercise (M): 33,409 (derivative) @ $0EDGAR
2022-12-054Justice Angela — Chief People OfficerOption exercise (M): 59,576 · Sale (S): 2,273 @ $1.39 · Option exercise (M): 50,889 (derivative) @ $0 · Option exercise (M): 2,840 (derivative) @ $0 · Option exercise (M): 5,847 (derivative) @ $0EDGAR
2022-12-054Menzel Garry E — President & CEO, DirectorOption exercise (M): 221,058 · Sale (S): 8,408 @ $1.39 · Option exercise (M): 158,795 (derivative) @ $0 · Option exercise (M): 40,881 (derivative) @ $0 · Option exercise (M): 21,382 (derivative) @ $0EDGAR

Recent 8-K events — TCR2 THERAPEUTICS INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2023-06-018-K2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2023-05-308-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2023-05-248-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2023-05-228-K8.01 — Other EventsEDGAR
2023-05-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2023-03-238-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2023-03-108-K7.01 — Regulation FD DisclosureEDGAR
2023-03-068-K1.01 — Entry into a Material Definitive Agreement
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-01-058-K?
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-01-038-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=TCRR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs